The skin microbiome in atopic dermatitis and its relationship to emollients

Journal of Cutaneous Medicine and Surgery

Volumn 20, Issue 1, 2016, Pages 21-28

  Lynde, Charles W ^a   Andriessen, Anneke ^b   Bertucci, Vince ^a   McCuaig, Catherine ^c   Skotnicki, Sandy ^a,d   Weinstein, Miriam ^a   Wiseman, Marni ^e   Zip, Catherine ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atopic Dermatitis; Dermatitis; Dermatology; Skin Microbiome

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYCLOSPORIN; DERMATOLOGICAL AGENT; EMOLLIENT AGENT; GENOMIC DNA; IRRITANT AGENT; MESSENGER RNA; METHOTREXATE; MOISTURIZER AGENT; PROTEIN KINASE C; RNA 16S; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIOXIDANT;

ATOPIC DERMATITIS; BACTERIUM CULTURE; BIOLOGICAL THERAPY; BIOMASS; CANADA; CLINICAL PRACTICE; CORYNEBACTERIUM; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA PURIFICATION; DYSBIOSIS; EARWAX TRANSPLANTATION; FECAL MICROBIOTA TRANSPLANTATION; HOST PATHOGEN INTERACTION; HUMAN; LANGERHANS CELL; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PHOTOTHERAPY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPIONIBACTERIUM; REVIEW; RRNA GENE; SKIN BIOPSY; SKIN DISEASE; SKIN DYSBIOSIS; SKIN MICROBIOME; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VITREOSCILLA; VITREOSCILLA FILIFORMIS; DERMATITIS, ATOPIC; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; DERMATITIS, ATOPIC; EMOLLIENTS; HUMANS; MICROBIOTA; SKIN;

EID: 84959373055     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/1203475415605498     Document Type: Review

References (30)

1. The NIH HMP Working Group et al. The NIH HMP Human Microbiome Project. Genome Res. 2009; 19:2317-2323.
2. Kong HH, Segre JA. Skin microbiome: looking back to move forward. J Invest Dermatol. 2012; 132:933-939.
3. Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol. 2013; 69:143-155.
4. Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009; 324:1190-1192.
5. Johnson CL, Versalovic J. The human microbiome and its potential importance to paediatrics. Pediatrics. 2012; 129:950-960.
6. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009; 326:1694-1697.
7. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. 2011; 12(1):6.
8. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011; 9(4):281.
9. Shaw TE, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Childrens Health. J Invest Dermatol. 2011; 131:67-73.
10. Hanifin JM, Reed ML. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007; 18:82-91.
11. Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges. 2009; 7:S1-S16.
12. Halioua B, Richard MA. Update on chronic hand eczema. Ann Dermatol Venereol. 2010; 137(4):315-327.
13. Hrabalek A, Vavrova K. Synthesis and structure-Activity. Relationships of skin ceramides. Curr Med Chem. 2010; 17:2301-2324.
14. Lebwohl M, Hermann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005; 76 (suppl 6):7-12.
15. Novotny J, Hrabalek A, Vavrova K. Synthesis and structureactivity relationships of skin ceramides. Curr Med Chem. 2010; 17:2301-2324.
16. Cramer C, Link E, Horster M, et al. Elder siblings enhance the effect of filaggrin mutations on childhood eczema: results from the 2 birth cohort studies LISAplus and GINIplus. J Allergy Clin Immunol. 2010; 125:1254-1260.
17. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347:1151-1160.
18. Cogen AL, Yamasaki K, Sanchez KM, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol. 2010; 130:192-200.
19. Nakatsuji T, Gallo RL. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011; 131(10):1974-1980.
20. Seite S, Flores GE, Henley JB, et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol. 2014; 13(11):1365-1372.
21. Gueniche A, Knaudt B, Schuck E, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebocontrolled clinical study. Br J Dermatol. 2008; 159:1357-1363.
22. Mahe YF, Perez MJ, Tacheau C, et al. A new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013; 6:191-196.
23. Stamatas GN, Capone K. New findings and the impact of infant skin microbiota on product development. Cosmetics and Toiletries. 2014; 129(2):54.
24. Kong HH. Skin microbiome: genomics based insights into the diversity and role of skin microbes. Trends Mol Med. 2011; 17(6):320-328.
25. Rosenthal M, Goldberg D, Aiello A, Larson E, Foxman B. Skin microbiota: microbial community structure and its potential association with health and disease. Infect Genet Evol. 2011; 11:839-848.
26. Gallo RL, Nakatsuji T, EEMCO Group. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011; 131(10):1974-1980.
27. Lynde C, Barber K, Claveau J, et al. Canadian practical guide for the treatment and management of atopic dermatitis. J Cutan Med Surg. 2005; 8(suppl 5):1-9.
28. Lynde C, Guenther L, Diepgen TL, et al. Canadian hand dermatitis management guidelines. J Cutan Med Surg. 2010; 14:267-284.
29. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000; 4(37): 1-191.
30. Kircik L. Effect of skin barrier emulsion cream vs a conventional moisturizer on transepidermal water loss and corneometry in atopic dermatitis: A pilot study. J Drugs Dermatol. 2014; 13(12):1482-1484.